SMTL ID : 4x0w.1

The crystal structure of mupain-1-17 in complex with murinised human uPA

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MRZ: piperidine-1-carboximidamide(Covalent)

MRZ.1: 13 residues within 4Å: Chain A: A.6 Chain B: D.192, S.193, C.194, Q.195, S.198, V.216, W.218, G.219, G.221, C.222, G.229 Ligands: SO4.2 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:V.216 Hydrogen bonds: B:S.193, B:S.193, B:G.221 Salt bridges: B:D.192, B:D.192

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain B: C.31, H.46, Q.195, G.196, D.197, S.198 Ligands: MRZ.1 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:G.196, B:D.197, B:S.198 Salt bridges: B:H.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jiang, L. et al., Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues. Int.J.Biochem.Cell Biol. (2015)

Release Date

2015-10-21

Peptides

mupain-1-17: A
Urokinase-type plasminogen activator: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
P

B
U

mupain-1-17

Urokinase-type plasminogen activator

Related Entries With Identical Sequence